NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Price (delayed)
$0.86
Market cap
$26.54M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.26
Enterprise value
$25.64M
Highlights
NMTC's revenue has surged by 153% since the previous quarter
The gross margin has soared by 151% YoY and by 110% QoQ
NEUROONE MEDICAL TECHNOLOGIES's equity has decreased by 34% YoY
The company's debt rose by 22% QoQ
Key stats
What are the main financial stats of NMTC
Market
Valuations
Earnings
Shares outstanding
30.86M
Market cap
$26.54M
Enterprise value
$25.64M
Price to earnings (P/E)
N/A
Price to book (P/B)
9.04
Price to sales (P/S)
3.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.93
Revenue
$8.75M
Gross profit
$5.74M
Operating income
-$6.79M
Net income
-$7.19M
EBIT
-$7.19M
EBITDA
-$6.82M
Free cash flow
-$7.1M
Per share
Balance sheet
Liquidity
EPS
-$0.26
EPS diluted
-$0.26
Free cash flow per share
-$0.23
Book value per share
$0.1
Revenue per share
$0.28
TBVPS
$0.21
Total assets
$6.49M
Total liabilities
$3.56M
Debt
$237,377
Equity
$2.94M
Working capital
$4.14M
Debt to equity
0.08
Current ratio
3.64
Quick ratio
2.23
Net debt/EBITDA
0.13
Margins
Efficiency
Dividend
EBITDA margin
-78%
Gross margin
65.6%
Net margin
-82.2%
Operating margin
-77.6%
Return on assets
-129.7%
Return on equity
-270.6%
Return on invested capital
-324.2%
Return on capital employed
-146%
Return on sales
-82.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NMTC stock price
How has the NEUROONE MEDICAL TECHNOLOGIES stock price performed over time
Intraday
-1.13%
1 week
-2.27%
1 month
-22.87%
1 year
-30.08%
YTD
4.13%
QTD
1.15%
Financial performance
How have NEUROONE MEDICAL TECHNOLOGIES's revenue and profit performed over time
Revenue
$8.75M
Gross profit
$5.74M
Operating income
-$6.79M
Net income
-$7.19M
Gross margin
65.6%
Net margin
-82.2%
NMTC's revenue has surged by 153% since the previous quarter
The gross margin has soared by 151% YoY and by 110% QoQ
NMTC's operating margin has soared by 84% YoY and by 77% from the previous quarter
The company's net margin has surged by 83% YoY and by 77% QoQ
Growth
What is NEUROONE MEDICAL TECHNOLOGIES's growth rate over time
Valuation
What is NEUROONE MEDICAL TECHNOLOGIES stock price valuation
P/E
N/A
P/B
9.04
P/S
3.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.93
The EPS has soared by 62% year-on-year and by 43% since the previous quarter
The P/B is 40% below the last 4 quarters average of 15.3 but 5% above the 5-year quarterly average of 8.7
NEUROONE MEDICAL TECHNOLOGIES's equity has decreased by 34% YoY
NMTC's revenue has surged by 153% since the previous quarter
The price to sales (P/S) is 92% lower than the 5-year quarterly average of 38.2 and 50% lower than the last 4 quarters average of 6.1
Efficiency
How efficient is NEUROONE MEDICAL TECHNOLOGIES business performance
The ROS has soared by 83% year-on-year and by 77% since the previous quarter
The company's return on invested capital has surged by 66% YoY and by 57% QoQ
NMTC's ROA is up by 43% from the previous quarter and by 35% YoY
The return on equity is up by 34% since the previous quarter
Dividends
What is NMTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NMTC.
Financial health
How did NEUROONE MEDICAL TECHNOLOGIES financials performed over time
The total assets is 82% greater than the total liabilities
NMTC's total liabilities has soared by 153% YoY but it is down by 22% from the previous quarter
NMTC's current ratio has surged by 74% since the previous quarter
The company's debt is 92% lower than its equity
NMTC's debt to equity has shrunk by 67% QoQ
NEUROONE MEDICAL TECHNOLOGIES's equity has decreased by 34% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.